<?xml version="1.0" ?>
<document version="1.8" entity_encoding="single">
  <page number="1">
    <text>Haematology and Dentistry 1:
Red Blood Cells (Anaemia)

2026 DENT5311 DMD3

**Dr Jee-Yun Leung**
Specialist in Special Needs Dentistry
Senior Lecturer | University of Western Australia
Consultant | Fiona Stanley Hospital</text>
    <formatted_text>2026 DENT5311 DMD3

*Dr Jee-Yun Leung*

- Specialist in Special Needs Dentistry
- Senior Lecturer | University of Western Australia
- Consultant | Fiona Stanley Hospital</formatted_text>
  </page>
  <page number="2">
    <text># Lecture Outcomes

*   1. Review the role of RBCs, systemic disorders and treatments which affect their structure and function, and general management
*   2. Review the oral manifestations of disorders of RBCs
*   3. Risk assess the implications of RBC disorders, and the treatment modifications required, when planning dental procedures</text>
    <formatted_text>1. Review the role of RBCs, systemic disorders and treatments which affect their structure and function, and general management
2. Review the oral manifestations of disorders of RBCs
3. Risk assess the implications of RBC disorders, and the treatment modifications required, when planning dental procedures</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:00:17" confidence="5" anchor="Risk assess the implications of RBC disorders, and the treatment modifications r">
- ==This lecture forms the first of three haematology lectures, covering red blood cells before white blood cells and platelets, coagulation and bleeding disorders==</insert>
      <insert timestamp="00:01:19" confidence="11" anchor="### **Blood Components**  4 main components:  1. Plasma 2. Red blood cells 3. Wh">

&gt; [!note] Lecturer — Blood Separation
&gt; Blood can be separated by centrifugation into three visible layers.
&gt;
&gt; - Plasma forms the pale yellow liquid matrix carrying the blood cells.
&gt; - The buffy coat is less than 1% of total blood volume and contains leukocytes and platelets.
&gt; - Leukocytes in the buffy coat include monocytes, lymphocytes, eosinophils, basophils and neutrophils.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="0,137,169,853" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="clipart">
        <description>A vertical red banner with thin white curved lines running across it, resembling a decorative border or background element.</description>
      </img>
    </images>
  </page>
  <page number="3">
    <text>Blood

4 main components:
1. Plasma
2. Red blood cells
3. White blood cells
4. Platelets

55% Plasma
Water
Ions
Proteins
Nutrients
Wastes
Gases
1%
platelets
White blood cells
44% Red blood cells

![Components of Blood](L5.1 haematology 1 RBC_figures/img_b017dbb0e31f9ca5.webp)
![](L5.1 haematology 1 RBC_figures/img_08478bcf9665c1dc.webp)</text>
    <formatted_text>Blood

4 main components:

1. Plasma
2. Red blood cells
3. White blood cells
4. Platelets

#### Composition by Volume

- 55% Plasma
  - Water
  - Ions
  - Proteins
  - Nutrients
  - Wastes
  - Gases
- 1% Platelets and white blood cells
- 44% Red blood cells</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:01:10" confidence="4" anchor="- 55% Plasma   - Water   - Ions   - Proteins   - Nutrients   - Wastes   - Gases ">

&gt; [!note] Lecturer — Plasma Composition
&gt; Plasma carries antibodies, while its water and ions help provide osmotic balance. Erythrocytes comprise approximately 45% of total blood volume.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="31,126,668,697" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L5.1 haematology 1 RBC_figures/img_b017dbb0e31f9ca5.webp" caption="Components of Blood">
        <description>A graphic illustration of a red blood cell, depicted as an orange biconcave disc with the label 'Blood' centered on it. To the right is a text list identifying the '4 main components: 1. Plasma, 2. Red blood cells, 3. White blood cells, 4. Platelets'.</description>
      </img>
      <img order="1" bbox="721,380,960,699" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_08478bcf9665c1dc.webp">
        <description>A labelled diagram illustrating the components of blood within a test tube, showing three distinct layers based on volume percentage. The top layer is yellow and labeled '55% Plasma' with sub-labels for its constituents (Water, Ions, Proteins, Nutrients, Wastes, Gases). The thin middle layer is blue-gray and labeled '1%', encompassing platelets and white blood cells, while the bottom red layer is labeled '44% Red blood cells'. Small illustrations of the specific cell types accompany their respective labels.</description>
      </img>
    </images>
  </page>
  <page number="4">
    <text>
**Adapted from Kumar and Clark’s Clinical Medicine (11th ed, 2025)**

Haemopoietic stem cell
Common myeloid progenitor
Common lymphoid progenitor
Megakaryocyte erythroid progenitor
Granulocyte macrophage progenitor
Thymus
Megakaryocyte
Erythroblast
B cell progenitor
T cell progenitor
Platelet
Erythrocyte
Neutrophil
Eosinophil
Basophil
Dendritic cell
B cell
T cell
NK cell

![Formation of Blood Cells](L5.1 haematology 1 RBC_figures/img_16949ba82d28ea4f.webp)</text>
    <formatted_text>*Adapted from Kumar and Clark's Clinical Medicine (11th ed, 2025)*

#### Cell Lineage

- Haemopoietic stem cell
  - Common myeloid progenitor
    - Megakaryocyte erythroid progenitor
      - Megakaryocyte → Platelet
      - Erythroblast → Erythrocyte
    - Granulocyte macrophage progenitor
      - Neutrophil
      - Eosinophil
      - Basophil
      - Dendritic cell
  - Common lymphoid progenitor
    - Thymus
      - T cell progenitor → T cell
    - B cell progenitor → B cell
    - NK cell</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:02:17" confidence="10" anchor="- B cell progenitor → B cell     - NK cell">

&gt; [!note] Lecturer — Haemopoietic Disorders
&gt; Blood disorders can be organised according to the affected cell type, including red blood cells, white blood cells and the coagulation system.
&gt;
&gt; - Anaemias are the most common red blood cell disorders and involve a deficiency.
&gt; - Many significant white blood cell disorders involve excessive proliferation that results in malignant transformation.
&gt; - Platelet abnormalities may result in bleeding disorders.
&gt; - These categories are closely linked: a disorder affecting one cell type can affect the entire haemopoietic system and alter other cell types.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="63,235,885,823" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_16949ba82d28ea4f.webp" caption="Formation of Blood Cells">
        <description>This flowchart illustrates the hierarchy of haematopoiesis, showing how a Haemopoietic stem cell differentiates into Common myeloid and Common lymphoid progenitors. The diagram traces these pathways down to specific mature blood cells, including Platelets, Erythrocytes, Neutrophils, Eosinophils, Basophils, Dendritic cells, B cells, T cells, and NK cells.</description>
      </img>
    </images>
  </page>
  <page number="5">
    <text>Haemopoietic system

Bone marrow
Liver
Lymph nodes
Spleen
Thymus

Thymus gland
Liver
Spleen
Lymph nodes
Bone marrow

Adapted from Scully (2014) – Medical Problems in Dentistry 7th ed

![](L5.1 haematology 1 RBC_figures/img_a6a15e2cd8ffbd5a.webp)</text>
    <formatted_text>#### Haemopoietic System

- Bone marrow
- Liver
- Lymph nodes
- Spleen
- Thymus

*Adapted from Scully (2014) – Medical Problems in Dentistry 7th ed*</formatted_text>
    <images>
      <img order="0" bbox="0,126,981,879" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_a6a15e2cd8ffbd5a.webp">
        <description>A labelled anatomical diagram of the human torso illustrating the components of the haemopoietic system. The figure points out specific organs and tissues, with labels identifying the Thymus gland, Liver, Spleen, Lymph nodes (located in the groin area), and Bone marrow (in the femur). A text box on the left lists these same structures: Bone marrow, Liver, Lymph nodes, Spleen, and Thymus.</description>
      </img>
    </images>
  </page>
  <page number="6">
    <text>Haemopoiesis

*   Blood cell formation
*   Occurs in haemopoietic system

Prenatal Postnatal

Hemopoiesis

Yolk sac
Bone marrow
Liver
Spleen
Tibia
Femur
Vertebra
Sternum
Rib

1 2 3 4 5 6 7 8 9 10 20 30 40 50 60 70
Fetal months Birth Age in years

![](L5.1 haematology 1 RBC_figures/img_b4d8412898114184.webp)</text>
    <formatted_text>- Blood cell formation
- Occurs in haemopoietic system

#### Prenatal and Postnatal Haemopoiesis

- Prenatal: yolk sac, liver, spleen
- Postnatal: bone marrow

Sites of haemopoiesis over time include bone marrow, liver, spleen, tibia, femur, vertebra, sternum, and rib, spanning fetal months, birth, and age in years (1–70).</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:03:33" confidence="17" anchor="Sites of haemopoiesis over time include bone marrow, liver, spleen, tibia, femur">

&gt; [!note] Lecturer — Prenatal Haemopoiesis
&gt; Blood cell production begins before birth while the embryo is in the uterus. By approximately week three, the yolk sac produces a less-developed type of red blood cell; during months two and three, red blood cells and platelets are produced in the liver and spleen, while white blood cells are produced in the liver, spleen and thymus.
&gt;
&gt; - By month five, most blood cell production occurs in the bone marrow, although the thymus, spleen and other lymphoid tissues continue producing some white blood cells.
&gt; - After birth, most production takes place in the bone marrow from infancy into adulthood, while lymphocytes are produced and develop in the thymus.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="423,288,929,707" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="chart" path="L5.1 haematology 1 RBC_figures/img_b4d8412898114184.webp">
        <description>A stacked area chart illustrating the timeline of hemopoiesis, divided into prenatal and postnatal phases. The x-axis tracks time from fetal months (1-9) through birth to age in years (up to 70), while colored areas represent different organs involved at each stage: Yolk sac (yellow), Liver (orange), Spleen (green), and Bone marrow (red). Lines extending into the postnatal section indicate specific bone sites where hematopoiesis continues, including Tibia, Femur, Vertebra, Sternum, and Rib.</description>
      </img>
    </images>
  </page>
  <page number="7">
    <text>Blood tests reference values

&lt;table&gt;
  &lt;tr&gt;
    &lt;th&gt;Blood parameter&lt;/th&gt;
    &lt;th&gt;Normal range&lt;/th&gt;
    &lt;th&gt;Units&lt;/th&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;White cell count&lt;/td&gt;
    &lt;td&gt;3.0 – 10.0&lt;/td&gt;
    &lt;td&gt;x 10⁹/L&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;Neutrophils&lt;/td&gt;
    &lt;td&gt;2.0 – 7.5&lt;/td&gt;
    &lt;td&gt;x 10⁹/L&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;Haemoglobin&lt;/td&gt;
    &lt;td&gt;115 – 155 (female)&lt;/td&gt;
    &lt;td&gt;g/L&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;130 – 170 (male)&lt;/td&gt;
    &lt;td&gt;g/L&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;Platelets&lt;/td&gt;
    &lt;td&gt;150 - 400&lt;/td&gt;
    &lt;td&gt;x 10⁹/L&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

![](L5.1 haematology 1 RBC_figures/img_2cbd934771052ec4.webp)</text>
    <formatted_text>| Blood parameter | Normal range | Units |
| --- | --- | --- |
| White cell count | 3.0 – 10.0 | x 10⁹/L |
| Neutrophils | 2.0 – 7.5 | x 10⁹/L |
| Haemoglobin | 115 – 155 (female) | g/L |
|  | 130 – 170 (male) | g/L |
| Platelets | 150 – 400 | x 10⁹/L |</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:04:29" confidence="4" anchor="| Platelets | 150 – 400 | x 10⁹/L |">

&gt; [!note] Lecturer — Blood Test Interpretation
&gt; Haemoglobin differs between females and males partly because of menstruation. Blood results are clinically important because values outside the expected range can affect dental treatment.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="306,401,821,689" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L5.1 haematology 1 RBC_figures/img_2cbd934771052ec4.webp">
        <description>A three-column table listing reference values for common blood parameters, including white cell count, neutrophils, haemoglobin (separated by sex), and platelets. The columns display the parameter name, its normal numerical range, and the corresponding units of measurement.</description>
      </img>
    </images>
  </page>
  <page number="8">
    <text/>
  </page>
  <page number="9">
    <text>*   **Erythrocytes**: responsible for oxygen carriage from lungs to tissues
    *   120 day lifespan
    *   Broken down in spleen
*   **Erythropoiesis**: red blood cell production

Red Blood Cells
(Erythrocytes)

![↓ O₂ delivery to tissues → Kidneys ↑ Erythropoietin secretion → Bone Marrow ↑ Production of erythrocytes → Blood ↑ O₂ carrying capacity → Restoration of O₂ delivery](L5.1 haematology 1 RBC_figures/img_11e0dc8e292b3c0d.webp)</text>
    <formatted_text>Red Blood Cells (Erythrocytes)

- **Erythrocytes**: responsible for oxygen carriage from lungs to tissues
  - 120 day lifespan
  - Broken down in spleen
- **Erythropoiesis**: red blood cell production</formatted_text>
    <images>
      <img order="0" bbox="150,405,370,830" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_11e0dc8e292b3c0d.webp" caption="↓ O₂ delivery to tissues → Kidneys ↑ Erythropoietin secretion → Bone Marrow ↑ Production of erythrocytes → Blood ↑ O₂ carrying capacity → Restoration of O₂ delivery">
        <description>A vertical flowchart illustrates the physiological feedback loop regulating erythropoiesis. It traces a sequence from decreased oxygen delivery to tissues, leading to increased erythropoietin secretion by the kidneys, which stimulates bone marrow to produce more erythrocytes, thereby increasing blood oxygen-carrying capacity and restoring oxygen delivery.</description>
      </img>
    </images>
  </page>
  <page number="10">
    <text>Haemoglobin (Hb)

**Haemoglobin:**
*   Protein contained by mature erythrocytes
*   4 globin chains (2 alpha, 2 beta)
*   Degradation:
    *   Hb $\rightarrow$ haem $\rightarrow$ bilirubin in the liver

Haemoglobin
(Hb)

![](L5.1 haematology 1 RBC_figures/img_35d1103784c50ec2.webp)</text>
    <formatted_text>Haemoglobin (Hb)

- Protein contained by mature erythrocytes
- 4 globin chains (2 alpha, 2 beta)
- Degradation:
  - Hb → haem → bilirubin in the liver</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:05:25" confidence="13" anchor="- Degradation:     - Hb → haem → bilirubin in the liver">

&gt; [!note] Lecturer — Red Cell Regulation
&gt; When oxygen delivery to tissues decreases, the kidneys detect the reduction and trigger erythropoietin production, increasing red blood cell production in the bone marrow.
&gt;
&gt; - Red blood cells develop from undifferentiated pluripotent stem cells through immature intermediate cells and reticulocytes.
&gt; - After approximately 120 days, damaged red blood cells are phagocytosed by macrophages in the bone marrow, liver and spleen, and their components are recycled.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="128,482,473,762" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_35d1103784c50ec2.webp">
        <description>A schematic ribbon diagram illustrating the quaternary structure of a haemoglobin molecule. The model displays four distinct globin protein chains arranged together, each containing a central heme group with an iron ion.</description>
      </img>
    </images>
  </page>
  <page number="11">
    <text/>
  </page>
  <page number="12">
    <text>**Anaemia:** Disorder of red blood cells, defined as a reduction in the oxygen carrying capacity of the blood.

**Classification:** on the basis of
*   **Cause:**
    *   blood loss anaemia
    *   deficiency anaemia (reduced erythropoiesis)
    *   haemolytic anaemia (increased rate of RBC destruction)
*   **Red-cell size:**
    *   microcytic (MCV &lt;78fl)
    *   macrocytic (MCV &gt;99fl)
    *   normocytic (79 &lt; MCV &lt; 98fl)</text>
    <formatted_text>**Anaemia:** Disorder of red blood cells, defined as a reduction in the oxygen carrying capacity of the blood.

Classification on the basis of:

- **Cause:**
  - blood loss anaemia
  - deficiency anaemia (reduced erythropoiesis)
  - haemolytic anaemia (increased rate of RBC destruction)
- **Red-cell size:**
  - microcytic (MCV &lt;78fl)
  - macrocytic (MCV &gt;99fl)
  - normocytic (79 &lt; MCV &lt; 98fl)</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:08:30" confidence="2" anchor="Classification on the basis of:">

&gt; [!note] Lecturer — Classification Focus
&gt; The lecture focused primarily on classification by cause.
&gt; This approach helps explain how the anaemias develop.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="0,115,998,878" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="clipart" caption="Anaemia">
        <description>A decorative red speech bubble or callout shape containing the text 'Anaemia', serving as a visual label for the slide topic.</description>
      </img>
    </images>
  </page>
  <page number="13">
    <text>&lt;table&gt;
  &lt;tr&gt;
    &lt;th&gt;Microcytic anaemia&lt;br&gt;(MCV &amp;lt;78fl)&lt;/th&gt;
    &lt;th&gt;Macrocytic anaemia&lt;br&gt;(MCV &amp;gt;99fl)&lt;/th&gt;
    &lt;th&gt;Normocytic anaemeia&lt;br&gt;(79 &amp;lt; MCV &amp;lt; 98fl)&lt;/th&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;Iron deficiency&lt;br&gt;Thalassemia&lt;br&gt;Chronic disease&lt;/td&gt;
    &lt;td&gt;Vit B12 deficiency&lt;br&gt;Folate deficiency&lt;br&gt;Drugs (e.g. methotrexate, azathioprine)&lt;br&gt;Chronic alcohol intake&lt;br&gt;Liver disease&lt;br&gt;Hypothyroidism&lt;br&gt;Reticulocytosis&lt;br&gt;Pregnancy&lt;br&gt;Aplastic anaemia&lt;/td&gt;
    &lt;td&gt;Chronic diseases e.g. leukaemia&lt;br&gt;Liver disorders&lt;br&gt;Chronic inflammatory disease&lt;br&gt;Renal failure&lt;br&gt;Infection&lt;br&gt;Malignancy&lt;br&gt;Sickle cell disease&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

![Anaemia](L5.1 haematology 1 RBC_figures/img_070626914db1e658.webp)</text>
    <formatted_text>#### Microcytic anaemia (MCV &lt;78fl)

- Iron deficiency
- Thalassemia
- Chronic disease

#### Macrocytic anaemia (MCV &gt;99fl)

- Vit B12 deficiency
- Folate deficiency
- Drugs (e.g. methotrexate, azathioprine)
- Chronic alcohol intake
- Liver disease
- Hypothyroidism
- Reticulocytosis
- Pregnancy
- Aplastic anaemia

#### Normocytic anaemia (79 &lt; MCV &lt; 98fl)

- Chronic diseases e.g. leukaemia
- Liver disorders
- Chronic inflammatory disease
- Renal failure
- Infection
- Malignancy
- Sickle cell disease</formatted_text>
    <images>
      <img order="0" bbox="420,270,949,729" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L5.1 haematology 1 RBC_figures/img_070626914db1e658.webp" caption="Anaemia">
        <description>A three-column table classifying anaemia by mean corpuscular volume (MCV), listing specific causes under Microcytic, Macrocytic, and Normocytic headings.</description>
      </img>
    </images>
  </page>
  <page number="14">
    <text># Clinical Manifestations

Headache
Behavioural changes

Mucosal pallor
Oral ulceration
Sore/burning tongue
Angular stomatitis

Fatigue
Anorexia

Dyspnoea

Tachycardia
Palpitations
Cardiac failure

Splitting/
spooning of nails

Paraesthesia of
fingers/toes

**Box 8.9 Clinical features of anaemia**

*   Typically none in the early stages
*   General lassitude
*   Cardiorespiratory
    *   Dyspnoea
    *   Tachycardia
    *   Congestive cardiac failure
    *   Murmurs
    *   Palpitations
    *   Angina pectoris
*   Cutaneous
    *   Pallor
    *   Brittle nails
    *   Koilonychia (spoon-shaped nails – Iron deficiency)
*   Oral
    *   Sore mouth
    *   Ulceration
    *   Angular stomatitis
    *   Glossitis
    *   Burning mouth symptoms

![Fig. 8.22 Anaemia – features.](L5.1 haematology 1 RBC_figures/img_ee9c188a6dfec0fb.webp)</text>
    <formatted_text>#### Clinical Features of Anaemia (Box 8.9)

- Typically none in the early stages
- General lassitude
  - Fatigue
  - Anorexia
- Neurological/behavioural
  - Headache
  - Behavioural changes
  - Paraesthesia of fingers/toes
- Cardiorespiratory
  - Dyspnoea
  - Tachycardia
  - Congestive cardiac failure
  - Murmurs
  - Palpitations
  - Angina pectoris
  - Cardiac failure
- Cutaneous
  - Pallor (mucosal pallor)
  - Brittle nails
  - Koilonychia (spoon-shaped nails – Iron deficiency)
  - Splitting/spooning of nails
- Oral
  - Sore mouth
  - Ulceration
  - Angular stomatitis
  - Glossitis
  - Burning mouth symptoms
  - Sore/burning tongue</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:07:01" confidence="5" anchor="- Koilonychia (spoon-shaped nails – Iron deficiency)">
- ==Breathlessness or dyspnoea due to reduced oxygen carriage==
- ==Muscle cramps==
- ==Headaches, although these were described as less usual==
- ==Tachycardia, particularly when anaemia is severe, as the cardiovascular system attempts to circulate more oxygen==</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="128,280,445,781" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_ee9c188a6dfec0fb.webp" caption="Fig. 8.22 Anaemia – features.">
        <description>An anatomical illustration of a male figure showing the systemic clinical features of anaemia. Labels point to specific body regions indicating symptoms such as headache and behavioural changes (head), mucosal pallor and oral ulceration (mouth), tachycardia and dyspnoea (chest/lungs), fatigue (shoulder), splitting/spooning of nails (hands), and paraesthesia of fingers/toes (extremities).</description>
      </img>
    </images>
  </page>
  <page number="15">
    <text>Oral Manifestations

Iron Deficiency Anemia-
Oral Manifestations
Low iron levels can lead to early oral signs!

• Smooth, shiny, &quot;Beefy red&quot; tongue

• Burning &amp; tingling pain

• Cracks at the mouth corners

• Pale gums &amp; mucosa

• Painful Mouth Sores

Cause:
↓ haemoglobin → ↓ oxygen supply →
↓ epithelial regeneration and immunity

1 Atrophic Glossitis
Smooth, shiny, &quot;beefy red&quot; tongue due to loss of filiform papillae.
Caused by impaired epithelial turnover.
May cause altered taste (dysgeusia).

2 Burning Mouth Sensation
Burning or tingling pain without obvious lesions.
Due to mucosal atrophy + neural sensitivity.

3 Angular Cheilitis
Cracks at mouth corners.
Epithelial thinning + secondary Candida/Staph infection.
Often linked with iron ± B-complex deficiency.

4 Pale Oral Mucosa
Pale gums and inner lips.
Reduced hemoglobin → decreased tissue oxygenation.

5 Recurrent Oral Ulcers
Painful, slow-healing ulcers.
Impaired oxygen delivery delays mucosal repair.

![1. Atrophic Glossitis (Bald Tongue)](L5.1 haematology 1 RBC_figures/img_131bd123d5c9ce78.webp)
![2. Burning Mouth Sensation](L5.1 haematology 1 RBC_figures/img_28d915d427bc0f71.webp)
![3. Angular Cheilitis](L5.1 haematology 1 RBC_figures/img_279cd19e7db836e9.webp)
![4. Pale Oral Mucosa](L5.1 haematology 1 RBC_figures/img_5a29745d46536355.webp)
![5. Recurrent Oral Ulcers](L5.1 haematology 1 RBC_figures/img_0a3f5cb813ace512.webp)</text>
    <formatted_text>Low iron levels can lead to early oral signs!

- Smooth, shiny, &quot;beefy red&quot; tongue
- Burning &amp; tingling pain
- Cracks at the mouth corners
- Pale gums &amp; mucosa
- Painful mouth sores

**Cause:** ↓ haemoglobin → ↓ oxygen supply → ↓ epithelial regeneration and immunity

#### Iron Deficiency Anaemia — Oral Manifestations

1. **Atrophic Glossitis** — Smooth, shiny, &quot;beefy red&quot; tongue due to loss of filiform papillae. Caused by impaired epithelial turnover. May cause altered taste (dysgeusia).
2. **Burning Mouth Sensation** — Burning or tingling pain without obvious lesions. Due to mucosal atrophy + neural sensitivity.
3. **Angular Cheilitis** — Cracks at mouth corners. Epithelial thinning + secondary Candida/Staph infection. Often linked with iron ± B-complex deficiency.
4. **Pale Oral Mucosa** — Pale gums and inner lips. Reduced hemoglobin → decreased tissue oxygenation.
5. **Recurrent Oral Ulcers** — Painful, slow-healing ulcers. Impaired oxygen delivery delays mucosal repair.</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:08:02" confidence="6" anchor="**Cause:** ↓ haemoglobin → ↓ oxygen supply → ↓ epithelial regeneration and immun">

&gt; [!note] Lecturer — Oral Manifestations
&gt; The lecturer associated reduced haemoglobin and reduced oxygen supply with increased epithelial regeneration and changes in immunity.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="95,389,225,501" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_131bd123d5c9ce78.webp" caption="1. Atrophic Glossitis (Bald Tongue)">
        <description>A clinical photograph of a human tongue protruding from the mouth. The dorsal surface appears smooth, glossy, and erythematous (red), lacking the normal texture provided by filiform papillae.</description>
      </img>
      <img order="1" bbox="242,388,370,500" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_28d915d427bc0f71.webp" caption="2. Burning Mouth Sensation">
        <description>Clinical photo of an open mouth showing a red tongue with superimposed orange flame icons. The graphic overlay illustrates the burning sensation associated with this oral manifestation.</description>
      </img>
      <img order="2" bbox="96,549,226,640" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_279cd19e7db836e9.webp" caption="3. Angular Cheilitis">
        <description>Clinical photo showing the mouth of a patient with visible cracks, redness, and fissuring at the corners of the lips.</description>
      </img>
      <img order="3" bbox="242,548,370,641" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_5a29745d46536355.webp" caption="4. Pale Oral Mucosa">
        <description>A clinical close-up photograph of an open mouth showing the teeth, lips, and tongue. The oral mucosa and gums appear notably pale, illustrating the physical sign of pallor associated with anemia.</description>
      </img>
      <img order="4" bbox="97,691,227,794" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_0a3f5cb813ace512.webp" caption="5. Recurrent Oral Ulcers">
        <description>Clinical photo: A close-up view of an open mouth with the tongue protruding, displaying multiple small, round ulcers with white centers and red halos on the lateral surface.</description>
      </img>
    </images>
  </page>
  <page number="16">
    <text># Blood loss anaemia</text>
    <formatted_text>Blood loss anaemia</formatted_text>
  </page>
  <page number="17">
    <text>Blood Loss Anaemia

**Definition:** occurs after sustaining a wound in which there is acute blood loss

**Compensatory mechanism:**
*   immediate threat at this stage is hypovolomic shock (cf. anaemia) and surviving is the primary objective.
*   Kidneys retain salt and water to increase the blood volume.
*   Once stabilised, haemodilution begins and achieves its full effect within 2-3 days, masking the extent of the red cell loss.
*   Healthy patient with adequate iron stores: full recovery from this transient anaemia by utilising iron stores to increase erythropoiesis $\rightarrow$ complete cell replacement and correction of the anaemia</text>
    <formatted_text>**Definition:** occurs after sustaining a wound in which there is acute blood loss

#### Compensatory Mechanism

- Immediate threat at this stage is hypovolaemic shock (cf. anaemia) and surviving is the primary objective.
- Kidneys retain salt and water to increase the blood volume.
- Once stabilised, haemodilution begins and achieves its full effect within 2-3 days, masking the extent of the red cell loss.
- Healthy patient with adequate iron stores: full recovery from this transient anaemia by utilising iron stores to increase erythropoiesis → complete cell replacement and correction of the anaemia.</formatted_text>
  </page>
  <page number="18">
    <text>Deficiency anaemia
Iron, folate, Vit B12

![](L5.1 haematology 1 RBC_figures/img_1de648ad54559ede.webp)</text>
    <formatted_text>- Iron
- Folate
- Vit B12</formatted_text>
    <images>
      <img order="0" bbox="0,105,1000,892" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L5.1 haematology 1 RBC_figures/img_1de648ad54559ede.webp">
        <description>A red rectangular graphic containing the text 'Deficiency anaemia' followed by a list of associated nutrients: 'Iron, folate, Vit B12'. The box features a small triangular pointer at the bottom and is set against a background of faint concentric arcs.</description>
      </img>
    </images>
  </page>
  <page number="19">
    <text>Deficiency Anaemia

**Definition:** Caused by inadequate supply to the bone marrow of some substances necessary for haemopoiesis (Hb synthesis).

**Haematinics:** nutrients required to make red blood cells

• Vitamin B12 = 3 year store

• Iron = 12 month store

• Folate = 3 month store</text>
    <formatted_text>**Definition:** Caused by inadequate supply to the bone marrow of some substances necessary for haemopoiesis (Hb synthesis).

#### Haematinics

Nutrients required to make red blood cells:

- Vitamin B12 = 3 year store
- Iron = 12 month store
- Folate = 3 month store</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:32:06" confidence="3" anchor="Nutrients required to make red blood cells:  - Vitamin B12 = 3 year store - Iron">
- ==The shorter folate store means folate deficiency can develop more quickly than some other deficiency anaemias.==</insert>
    </audio_inserts>
  </page>
  <page number="20">
    <text>Iron Deficiency Anaemia

**Causes:**
• Malabsorption (e.g. Coeliac disease, Crohn’s disease)
• Nutritional deficiency (low iron intake – malnutrition, reduced meat diet)
• Excess demand (e.g. pregnancy, infancy)
• Chronic blood loss (e.g. especially GIT – peptic ulcers, haemorrhoids, colon cancer; menstruation)

**Features**
• Weakness
• Pallor
• Koilonychia (nail spooning)
• Hair loss

![](L5.1 haematology 1 RBC_figures/img_d65bd98dc1b7717c.webp)</text>
    <formatted_text>#### Causes

- Malabsorption (e.g. Coeliac disease, Crohn's disease)
- Nutritional deficiency (low iron intake – malnutrition, reduced meat diet)
- Excess demand (e.g. pregnancy, infancy)
- Chronic blood loss (e.g. especially GIT – peptic ulcers, haemorrhoids, colon cancer; menstruation)

#### Features

- Weakness
- Pallor
- Koilonychia (nail spooning)
- Hair loss</formatted_text>
    <images>
      <img order="0" bbox="627,592,897,793" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_d65bd98dc1b7717c.webp">
        <description>Clinical photo: A close-up of a fingernail exhibiting koilonychia, characterized by a concave, spoon-shaped deformity of the nail plate.</description>
      </img>
    </images>
  </page>
  <page number="21">
    <text>Iron Deficiency Anaemia

**General Management:**
*   Dietary iron
    *   Heme iron: animal tissues - higher absorption rate
    *   Non-heme iron: plants, fortified foods – lower absorption rate
    *   Enhancers of non-heme absorption: Vitamin C
    *   Inhibitors of non-heme absorption: phytates (in grains/beans), oxalates, phosphates present in plant foods ; tannin in tea/coffee/wine; calcium in diary, oxalates

*   Iron supplements:
    *   Oral intake, may take few months to correct, constipation

*   Iron infusions (IV)

![Maltfer Tablets](L5.1 haematology 1 RBC_figures/img_2e8bdef25620ff93.webp)</text>
    <formatted_text>#### General Management

- Dietary iron
  - Heme iron: animal tissues – higher absorption rate
  - Non-heme iron: plants, fortified foods – lower absorption rate
  - Enhancers of non-heme absorption: Vitamin C
  - Inhibitors of non-heme absorption: phytates (in grains/beans), oxalates, phosphates present in plant foods; tannin in tea/coffee/wine; calcium in dairy, oxalates
- Iron supplements
  - Oral intake, may take few months to correct, constipation
- Iron infusions (IV)</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:11:48" confidence="4" anchor="Dietary iron   - Heme iron: animal tissues – higher absorption rate   - Non-heme">
- ==Multiferr was described as causing less constipation than some other oral iron preparations.==
- ==Iron infusions are frequently required during pregnancy.==</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="731,206,924,350" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_2e8bdef25620ff93.webp" caption="Maltfer Tablets">
        <description>A photograph of a retail box for Maltifer Tablets, an oral iron supplement. The packaging identifies the active ingredient as Iron polymaltose 370mg (equivalent to 100mg elemental iron per tablet) and includes warnings such as 'Keep out of reach of children'.</description>
      </img>
    </images>
  </page>
  <page number="22">
    <text># Vitamin B12 Deficiency Anaemia

**Vit B12:** role in synthesising and breaking down amino acids, and synthesising DNA/RNA.
*   Required to build new cells, especially blood, skin and mucosal cells.

**Cause:**
*   Usually defect in intrinsic factor (as a result of pernicious anaemia or gastrectomy)
*   occasionally ileum disease or resection
*   rarely congenital ileum absorption defect.

**Pernicious Anaemia:** autoimmune condition where the body cannot absorb vitamin B12 due to autoantibodies against gastric parietal cells, and/or intrinsic factor. Without intrinsic factor, Vit B12 is unable to form the complex to absorb in the terminal ileum.</text>
    <formatted_text>**Vit B12:** role in synthesising and breaking down amino acids, and synthesising DNA/RNA.

- Required to build new cells, especially blood, skin and mucosal cells.

#### Causes

- Usually defect in intrinsic factor (as a result of pernicious anaemia or gastrectomy)
- Occasionally ileum disease or resection
- Rarely congenital ileum absorption defect

#### Pernicious Anaemia

Autoimmune condition where the body cannot absorb vitamin B12 due to autoantibodies against gastric parietal cells, and/or intrinsic factor. Without intrinsic factor, Vit B12 is unable to form the complex to absorb in the terminal ileum.</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:12:40" confidence="7" anchor="Autoimmune condition where the body cannot absorb vitamin B12 due to autoantibod">

&gt; [!note] Lecturer — Pernicious Anaemia
&gt; Pernicious anaemia is a type of vitamin B12 deficiency anaemia. Gastric parietal cells are involved in producing intrinsic factor, so their impairment can prevent effective vitamin B12 absorption.
</insert>
    </audio_inserts>
  </page>
  <page number="23">
    <text>Vitamin B12 Deficiency Anaemia

**Additional Features:**
*   ** Burning tongue
*   Neurological symptoms (paraesthesia of extremities) e.g. Loss of toe positional sense and diminished perception of tuning fork vibration, unsteady movement, muscle weakness
*   shortness of breath
*   slower healing
*   premature greying of hair
*   increased homocysteine

**Treatment:** parenteral or high-dose oral replacement</text>
    <formatted_text>#### Additional Features

- Burning tongue
- Neurological symptoms (paraesthesia of extremities) e.g. loss of toe positional sense and diminished perception of tuning fork vibration, unsteady movement, muscle weakness
- Shortness of breath
- Slower healing
- Premature greying of hair
- Increased homocysteine

#### Treatment

Parenteral or high-dose oral replacement.</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:13:05" confidence="2" anchor="- Burning tongue - Neurological symptoms (paraesthesia of extremities) e.g. loss">
- ==Burning tongue is particularly relevant in dentistry.==</insert>
    </audio_inserts>
  </page>
  <page number="24">
    <text>Folic Acid Deficiency Anaemia

**Folic Acid:**
*   needed by body to synthesise and break down amino acids, and synthesise DNA/RNA to build new cells, especially blood, skin and mucosal cells.
*   Plays a role in: myelination (liposynthesis to maintain healthy CNS), RBC production, DNA/RNA synthesis $\rightarrow$ joint metabolism with Vit B12
*   Found in fresh leafy vegetables (spinach, kale, Brussel sprouts, asparagus).
*   Absorbed from proximal small intestine

**Cause:**
*   Usually dietary deficiency
*   Some caused by disease of small intestine (e.g. Coeliac)
*   Cancer patients treated with methotrexate</text>
    <formatted_text>#### Folic Acid

- Needed by body to synthesise and break down amino acids, and synthesise DNA/RNA to build new cells, especially blood, skin and mucosal cells.
- Plays a role in: myelination (liposynthesis to maintain healthy CNS), RBC production, DNA/RNA synthesis → joint metabolism with Vit B12
- Found in fresh leafy vegetables (spinach, kale, Brussel sprouts, asparagus).
- Absorbed from proximal small intestine

#### Causes

- Usually dietary deficiency
- Some caused by disease of small intestine (e.g. Coeliac)
- Cancer patients treated with methotrexate</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:14:16" confidence="6" anchor="- Usually dietary deficiency - Some caused by disease of small intestine (e.g. C">

&gt; [!note] Lecturer — Methotrexate Treatment
&gt; Methotrexate inhibits an enzyme involved in folate synthesis. In cancer treatment, this inhibition is used to reduce DNA, RNA and protein synthesis.
</insert>
    </audio_inserts>
  </page>
  <page number="25">
    <text>&lt;h2&gt;Folic Acid Deficiency Anaemia&lt;/h2&gt;

**Features**
*   Similar to B12 deficiency
*   In pregnancy, predisposes foetus to neural tube defects and cleft lip/palate
*   Predisposes to IHD in adults

**Treatment**
*   Folic acid 5mg daily for at least 4 months (rapidly restores)</text>
    <formatted_text>#### Features

- Similar to B12 deficiency
- In pregnancy, predisposes foetus to neural tube defects and cleft lip/palate
- Predisposes to IHD in adults

#### Treatment

- Folic acid 5mg daily for at least 4 months (rapidly restores)</formatted_text>
    <audio_inserts count="3">
      <insert timestamp="00:14:42" confidence="8" anchor="- Similar to B12 deficiency - In pregnancy, predisposes foetus to neural tube de">
- ==Daily folic acid is recommended during pregnancy to help protect against neural tube defects.==</insert>
      <insert timestamp="00:33:42" confidence="5" anchor="- **Paroxysmal nocturnal haemoglobinuria**">

&gt; [!note] Lecturer — Aplastic Anaemia
&gt; Aplastic anaemia may cause general features of anaemia, including weakness, pallor and shortness of breath.
&gt;
&gt; - White cells and platelets may also be affected, causing increased susceptibility to infection, bleeding, purpura and petechiae.
&gt; - Management may include removal of the cause where possible, antibiotics, immunosuppression, blood transfusions and stem cell transplantation.
&gt; - Reported five-year survival was approximately 90% for patients under 40 and 70% for patients under 60, with prognosis decreasing with age.
</insert>
      <insert timestamp="00:21:29" confidence="4" anchor="- Infection is a major cause of death in sickle cell disease.">

&gt; [!note] Lecturer — Sickle Cell Complications
&gt; Sickle cell disease can produce multiple systemic complications through microemboli and vascular obstruction.
&gt;
&gt; - Involvement may extend to the lungs, kidneys, eyes, brain, liver, spleen and bone marrow.
&gt; - Splenic damage affects immunity because the spleen has an important role in immune function.
</insert>
    </audio_inserts>
  </page>
  <page number="26">
    <text>**Haemolytic anaemia**
Sickle Cell, Thalassaemia

![Haemolytic anaemia Sickle Cell, Thalassaemia](L5.1 haematology 1 RBC_figures/img_17b84a6eaca9b381.webp)</text>
    <formatted_text>Sickle Cell, Thalassaemia</formatted_text>
    <images>
      <img order="0" bbox="0,107,1000,890" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L5.1 haematology 1 RBC_figures/img_17b84a6eaca9b381.webp" caption="Haemolytic anaemia Sickle Cell, Thalassaemia">
        <description>A title card featuring a red rectangular box with white text reading 'Haemolytic anaemia' and 'Sickle Cell, Thalassaemia'. The graphic includes a small triangular pointer at the bottom and is set against a background of faint grey concentric arcs.</description>
      </img>
    </images>
  </page>
  <page number="27">
    <text>Haemolytic Anaemias

*   **Haemoglobinopathies (inherited abnormalities of Hb formation)**
    *   *Sickle cell anaemia / sickle cell trait (globin structure affected)
    *   *Thalassaemia (globin chain number diminished)
*   **Inherited abnormalities of erythrocyte structure or function**
    *   Hereditary spherocytosis (cell shape change)
    *   Glucose-6-phosphate dehydrogenase deficiency (cell membrane enzyme defect)
*   **Damage to erythrocytes**
    *   *Aplastic anaemia
    *   Malaria
    *   Anaemia of chronic disease
*   **Others**
    *   Pure red-cell aplasia
    *   Paroxysmal nocturnal haemoglobinuria</text>
    <formatted_text>- **Haemoglobinopathies (inherited abnormalities of Hb formation)**
  - Sickle cell anaemia / sickle cell trait (globin structure affected)
  - Thalassaemia (globin chain number diminished)
- **Inherited abnormalities of erythrocyte structure or function**
  - Hereditary spherocytosis (cell shape change)
  - Glucose-6-phosphate dehydrogenase deficiency (cell membrane enzyme defect)
- **Damage to erythrocytes**
  - Aplastic anaemia
  - Malaria
  - Anaemia of chronic disease
- **Others**
  - Pure red-cell aplasia
  - Paroxysmal nocturnal haemoglobinuria</formatted_text>
  </page>
  <page number="28">
    <text>Sickle Cell Anaemia/Trait - *infarcts*

*   **Sickling disorders:** hereditary disorder characterised by the presence of structurally abnormal Hb (point mutation in gene encoding for b-chain; Hb $\rightarrow$ HbS)
    *   **Sickle cell anaemia or disease** (HbSS): homozygous, usually a serious disease with widespread complications, frequently apparent in 3rd month of life. Sickle Cell Anaemia is most severe type of the group of sickle cell diseases.
    *   **Sickle cell trait** (HbSA): heterozygous and 10 times more common. Frequently asymptomatic, but sickle cell crises can be caused by low oxygen tension (GA, high altitudes, unpressurised aircraft).

*   **Epidemiology**
    *   Sickle cell trait carriage: Afro-Carribean (1/10), then India / Middle East / Mediterranean (1/100)</text>
    <formatted_text>- **Sickling disorders:** hereditary disorder characterised by the presence of structurally abnormal Hb (point mutation in gene encoding for β-chain; Hb → HbS)
  - **Sickle cell anaemia or disease** (HbSS): homozygous, usually a serious disease with widespread complications, frequently apparent in 3rd month of life. Sickle Cell Anaemia is most severe type of the group of sickle cell diseases.
  - **Sickle cell trait** (HbSA): heterozygous and 10 times more common. Frequently asymptomatic, but sickle cell crises can be caused by low oxygen tension (GA, high altitudes, unpressurised aircraft).

#### Epidemiology

- Sickle cell trait carriage: Afro-Caribbean (1/10), then India / Middle East / Mediterranean (1/100)</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:17:59" confidence="4" anchor="- Sickle cell trait carriage: Afro-Caribbean (1/10), then India / Middle East / ">
- ==The frequency encountered in dental practice depends on the treated population, migration patterns and the country in which the practitioner works; more sickle cell anaemia was encountered in the United Kingdom and Sydney than in Perth.==</insert>
    </audio_inserts>
  </page>
  <page number="29">
    <text>Sickle Cell Anaemia/Trait - *infarcts*

• **Cause:**
• On deoxygenation, HbS molecules undergo polymerisataion (crystallisation).
• The change in physical shape distorts the RBC, which assumes a sickle shape.
• Initially this shape deformation is reversible with reoxygenation, but damage occurs with every episode of sickling (e.g. loss of water and potassium, and accumulation with calcium)
• Eventually the sickle shape becomes permanent

Sickled RBC with mutated hemoglobin (HbS)
Glutamate
β6 position

![Normal RBC with normal hemoglobin (HbA)](L5.1 haematology 1 RBC_figures/img_e18e1b8e7f5fe72d.webp)
![](L5.1 haematology 1 RBC_figures/img_91e5ab95ef1c4608.webp)
![](L5.1 haematology 1 RBC_figures/img_c104672edca68f7f.webp)
![Valine](L5.1 haematology 1 RBC_figures/img_8f2a9870ee83056c.webp)</text>
    <formatted_text>#### Cause

- On deoxygenation, HbS molecules undergo polymerisation (crystallisation).
- The change in physical shape distorts the RBC, which assumes a sickle shape.
- Initially this shape deformation is reversible with reoxygenation, but damage occurs with every episode of sickling (e.g. loss of water and potassium, and accumulation with calcium).
- Eventually the sickle shape becomes permanent.

*Sickled RBC with mutated hemoglobin (HbS) — glutamate, β6 position*</formatted_text>
    <images>
      <img order="0" bbox="630,389,711,467" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_e18e1b8e7f5fe72d.webp" caption="Normal RBC with normal hemoglobin (HbA)">
        <description>A schematic diagram illustrating a normal red blood cell (RBC) with its characteristic biconcave disc shape, depicted as a smooth, round red structure with central pallor. This visual represents the healthy morphology associated with normal hemoglobin (HbA), contrasting with the sickled cells described in the context.</description>
      </img>
      <img order="1" bbox="638,668,707,732" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_91e5ab95ef1c4608.webp">
        <description>A chemical structure diagram showing the molecular formula of Glutamate, featuring a central carbon chain with carboxyl groups and an amino group.</description>
      </img>
      <img order="2" bbox="815,540,916,657" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L5.1 haematology 1 RBC_figures/img_c104672edca68f7f.webp">
        <description>A stylised, 3D rendering of a tangled cluster of red, tube-like structures forming a roughly spherical mass. This visualizes the polymerization and crystallization of Hemoglobin S (HbS) molecules that occurs within a sickled red blood cell upon deoxygenation.</description>
      </img>
      <img order="3" bbox="842,668,891,733" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L5.1 haematology 1 RBC_figures/img_8f2a9870ee83056c.webp" caption="Valine">
        <description>Skeletal structure diagram of the amino acid Valine, showing its isopropyl side chain, carboxylic acid group (COOH), and amino group (NH2).</description>
      </img>
    </images>
  </page>
  <page number="30">
    <text>Sickle Cell Anaemia/Trait - *infarcts*

• **Consequence of sickle cells**
    • *Membrane damage and dehydration of RBC*: renders them rigid and irreversibly sicked → mean lifespan reduced from 120 to 20 days as mononuclear phagocytes remove damaged RBCs → chronic extravascular haemolytic anaemia
    • *Widespread microvascular obstructions*: occurs in kidney &amp; spleen due to congestion of red pulp with masses of sickled RBC packed together → splenic erythrostasis → hypoxia → shrunken/fibrous spleen</text>
    <formatted_text>#### Consequences of Sickle Cells

- **Membrane damage and dehydration of RBC:** renders them rigid and irreversibly sickled → mean lifespan reduced from 120 to 20 days as mononuclear phagocytes remove damaged RBCs → chronic extravascular haemolytic anaemia
- **Widespread microvascular obstructions:** occurs in kidney &amp; spleen due to congestion of red pulp with masses of sickled RBC packed together → splenic erythrostasis → hypoxia → shrunken/fibrous spleen</formatted_text>
  </page>
  <page number="31">
    <text>Sickle Cell Anaemia/Trait - *infarcts*

*   **Features**
    *   Chronic anaemia
    *   Chronic hyperbilirubinaemia
    *   *Painful crisis (ie. vaso-occlusive crisis)
        *   Infarcts as a result of sickling: spleen, lungs, kidneys, eyes, cerebrovascular stroke
        *   Brought on by infection, dehydration, hypoxia, acidosis, cold.
    *   Haematological crises: caused by parovirus infection
    *   *Infections:
        *   Due to immune defect resulting from splenic infarction and dysfunction.
    *   Sequestration syndromes:
        *   sequestration of sickle cells in: lungs (impeding gas exchange $\rightarrow$ chest syndrome), spleen ($\rightarrow$ septicaemia), liver ($\rightarrow$ bowel dilatation)

Box 8.13 *Features of sickle cell anaemia*
*   Anaemia
*   Crises
    *   Painful crises
    *   Aplastic crises
    *   Dactylitis – painful osteitis in the hands (Fig. 8.35)
    *   Infarcts of central nervous system, lungs, kidney, spleen, bone
    *   Skin ulcers
*   Haemolysis
    *   Jaundice
    *   Gallstones
    *   Reticulocytosis
*   Impaired growth
*   Skeletal deformities
*   Susceptibility to infections

![Fig. 8.35 Dactylitis showing painful red swellings.](L5.1 haematology 1 RBC_figures/img_54057817f2697a39.webp)</text>
    <formatted_text>#### Features

- Chronic anaemia
- Chronic hyperbilirubinaemia
- **Painful crisis** (i.e. vaso-occlusive crisis)
  - Infarcts as a result of sickling: spleen, lungs, kidneys, eyes, cerebrovascular stroke
  - Brought on by infection, dehydration, hypoxia, acidosis, cold.
- Haematological crises: caused by parovirus infection
- **Infections:** due to immune defect resulting from splenic infarction and dysfunction.
- **Sequestration syndromes:** sequestration of sickle cells in lungs (impeding gas exchange → chest syndrome), spleen (→ septicaemia), liver (→ bowel dilatation)

#### Box 8.13 — Features of Sickle Cell Anaemia

- Anaemia
- Crises
  - Painful crises
  - Aplastic crises
  - Dactylitis – painful osteitis in the hands (Fig. 8.35)
  - Infarcts of central nervous system, lungs, kidney, spleen, bone
  - Skin ulcers
- Haemolysis
  - Jaundice
  - Gallstones
  - Reticulocytosis
- Impaired growth
- Skeletal deformities
- Susceptibility to infections</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:21:16" confidence="6" anchor="- Haematological crises: caused by parovirus infection">

&gt; [!note] Lecturer — Aplastic Crises
&gt; During an aplastic crisis, erythropoiesis suddenly and temporarily stops.
&gt;
&gt; - Reticulocytes disappear from the blood.
&gt; - The anaemia consequently worsens.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="827,201,957,359" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_54057817f2697a39.webp" caption="Fig. 8.35 Dactylitis showing painful red swellings.">
        <description>Clinical photo of an infant's hand showing marked redness and swelling on the palm, illustrating dactylitis.</description>
      </img>
    </images>
  </page>
  <page number="32">
    <text>Sickle Cell Anaemia/Trait - *infarcts*

*   **General Management**
    Main principles in treatment are to prevent trauma, infection, hypoxia, acidosis or dehydration
    *   regular blood pictures
    *   comprehensive care programmes
    *   regular folic acid
    *   exchange transfusions (remove sickled cells and replace defective cells) - heparinised
    *   fluids
    *   keep warm (clothes)
    *   long term antibiotics
    * Most pts on prophylactic penicillin too</text>
    <formatted_text>#### General Management

Main principles in treatment are to prevent trauma, infection, hypoxia, acidosis or dehydration:

- regular blood pictures
- comprehensive care programmes
- regular folic acid
- exchange transfusions (remove sickled cells and replace defective cells) — heparinised
- fluids
- keep warm (clothes)
- long term antibiotics
- most pts on prophylactic penicillin too</formatted_text>
  </page>
  <page number="33">
    <text>Oral Findings – Sickle Cell Anaemia

Increased radiolucency in posterior body of mandible

Enlarged haemopoietic maxilla with excessive OJ and OB (due to bone marrow hyperplasia)
Trigeminal neuropathy (due to osteomyelitis)
Painful infarcts in jaws (can be mistaken for toothache)
Enamel hypomineralisation and calcified pulp canals
Pulp symptoms and pulp necrosis in absence of obvious dental disease
Delayed skeletal maturation

Radiological features:
• Hypercementosis (dense lamina dura)
• Sparse mandibular trabecular bone pattern (due to bone marrow hyperplasia)
• Thickening/expansion of skull diploe with “hair-on-end” appearance
• Dense radio-opacities with “stepladder” trabeculae pattern (due to previous infarcts)

L

Increased radiolucency of the bone in the inferior body of the mandible
(Grossman S, Bailey E, Makdissi J. Oral aspects of sickle cell disease, Br Dent J. 2019; 226: 818)

due to micro-embolisms in sickle cell artery

![Increased radiolucency of the bone in the inferior body of the mandible (Grossman S, Bailey E, Makdissi J. Oral aspects of sickle cell disease, Br Dent J. 2019; 226: 818)](L5.1 haematology 1 RBC_figures/img_3f1f38500e38a4a9.webp)</text>
    <formatted_text>- Increased radiolucency in posterior body of mandible
- Enlarged haemopoietic maxilla with excessive OJ and OB (due to bone marrow hyperplasia)
- Trigeminal neuropathy (due to osteomyelitis)
- Painful infarcts in jaws (can be mistaken for toothache)
- Enamel hypomineralisation and calcified pulp canals
- Pulp symptoms and pulp necrosis in absence of obvious dental disease
- Delayed skeletal maturation

#### Radiological Features

- Hypercementosis (dense lamina dura)
- Sparse mandibular trabecular bone pattern (due to bone marrow hyperplasia)
- Thickening/expansion of skull diploe with &quot;hair-on-end&quot; appearance
- Dense radio-opacities with &quot;stepladder&quot; trabeculae pattern (due to previous infarcts)
- Increased radiolucency of the bone in the inferior body of the mandible — due to micro-embolisms in sickle cell artery

*Grossman S, Bailey E, Makdissi J. Oral aspects of sickle cell disease, Br Dent J. 2019; 226: 818.*</formatted_text>
    <images>
      <img order="0" bbox="57,286,528,578" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L5.1 haematology 1 RBC_figures/img_3f1f38500e38a4a9.webp" caption="Increased radiolucency of the bone in the inferior body of the mandible (Grossman S, Bailey E, Makdissi J. Oral aspects of sickle cell disease, Br Dent J. 2019; 226: 818)">
        <description>A panoramic dental radiograph (orthopantomogram) showing the maxilla and mandible with a full set of teeth. The image illustrates increased radiolucency in the inferior body of the mandible, appearing as a sparse trabecular bone pattern compared to the denser surrounding structures.</description>
      </img>
    </images>
  </page>
  <page number="34">
    <text>Thalassemia – *iron deposition*

• **Definition:** group of heterogenous autosomal dominant genetic disorders of Hb synthesis, characterized by a lack or decreased synthesis of globin chains.
    • May be severe (major; homozygous) or mild (minor;heterozygous)
    • α-thalassemia: α-globin chain synthesis is ↓
    • β-thalassemia: β-globin synthesis is ↓ or non-existent

• **Epidemiology:**
    • Alpha: south-east Asian, southern Chinese, sub-Saharan Africa, Middle East
    • Beta: Mediterranean</text>
    <formatted_text>- **Definition:** group of heterogenous autosomal dominant genetic disorders of Hb synthesis, characterized by a lack or decreased synthesis of globin chains.
  - May be severe (major; homozygous) or mild (minor; heterozygous)
  - α-thalassemia: α-globin chain synthesis is ↓
  - β-thalassemia: β-globin synthesis is ↓ or non-existent

#### Epidemiology

- Alpha: south-east Asian, southern Chinese, sub-Saharan Africa, Middle East
- Beta: Mediterranean</formatted_text>
    <audio_inserts count="4">
      <insert timestamp="00:16:45" confidence="5" anchor="- **Definition:** group of heterogenous autosomal dominant genetic disorders of ">

&gt; [!note] Lecturer — Sickle Cell and Thalassaemia
&gt; A key distinction is that sickle cell disease is associated particularly with infarcts, whereas thalassaemia is associated particularly with iron deposition.
</insert>
      <insert timestamp="00:27:17" confidence="7" anchor="- β-thalassemia: β-globin synthesis is ↓ or non-existent">

&gt; [!note] Lecturer — Alpha Globin Chains
&gt; Alpha thalassaemia may be relatively mild because there are four alpha-globin chains.
&gt;
&gt; - If all four alpha-globin chains are affected, the condition is not compatible with life and the individual dies in infancy.
&gt; - There are only two beta-globin chains, so abnormalities can produce more severe effects.
</insert>
      <insert timestamp="00:28:45" confidence="7" anchor="- Chelation therapy may create compliance difficulties, particularly during adol">

&gt; [!note] Lecturer — Thalassaemia Complications
&gt; Thalassaemia can be considered a disease associated with multiple secondary conditions because iron is deposited throughout the body.
&gt;
&gt; - Iron deposition may affect the liver, kidneys, heart, pancreas, thyroid, parathyroid and pituitary system.
&gt; - Cardiac deposition may cause cardiomyopathy and cardiac failure, while liver disease may include cirrhosis.
&gt; - Endocrine effects may include thyroid dysfunction and reduced sex hormones.
</insert>
      <insert timestamp="00:28:06" confidence="8" anchor="- Red blood cell destruction causes systemic iron overload because iron is relea">
- ==Alpha and beta globin chains are normally intended to match; unpaired alpha chains aggregate inside red blood cells and form insoluble precipitates that damage them.==</insert>
    </audio_inserts>
  </page>
  <page number="35">
    <text>Thalassemia – *iron deposition*

• **Cause – Beta thalassemia:** β-globin synthesis is ↓ or non-existent
   • Excess of unpaired α-chains → chains aggregate within the RBC and form insoluble precipitates → damages RBC → sequestration
   • Systemic iron overload due to mass destruction of RBCs
   • Can be life threatening in homozygous form</text>
    <formatted_text>#### Cause — Beta Thalassemia

β-globin synthesis is ↓ or non-existent:

- Excess of unpaired α-chains → chains aggregate within the RBC and form insoluble precipitates → damages RBC → sequestration
- Systemic iron overload due to mass destruction of RBCs
- Can be life threatening in homozygous form</formatted_text>
  </page>
  <page number="36">
    <text>Thalassemia – *iron deposition*

• **Clinical Presentation** – homozygotes
    • **Iron Overload from repeated transfusions:**
        • Thyroid &amp; parathyroid damage
        • pituitary (delayed puberty, short stature)
        • liver &amp; kidney damage
        • cardiac failure
        • pancreas (secondary diabetes)
        • skin (green/bronze pigmentation due to iron deposition)
        • low levels estrogen or testosterone
    • **Impact of Treatment:**
        • Regular hospital admissions for transfusions
        • disruption to family/school/social life
        • psychological implication of side effects
        • *compliance with chelation (particularly adolescence)*</text>
    <formatted_text>#### Clinical Presentation — Homozygotes

- **Iron Overload from repeated transfusions:**
  - Thyroid &amp; parathyroid damage
  - Pituitary (delayed puberty, short stature)
  - Liver &amp; kidney damage
  - Cardiac failure
  - Pancreas (secondary diabetes)
  - Skin (green/bronze pigmentation due to iron deposition)
  - Low levels estrogen or testosterone
- **Impact of Treatment:**
  - Regular hospital admissions for transfusions
  - Disruption to family/school/social life
  - Psychological implication of side effects
  - Compliance with chelation (particularly adolescence)</formatted_text>
  </page>
  <page number="37">
    <text>Thalassemia – *iron deposition*

• **General Management**
  • Regular blood transfusion (to treat anaemia)
  • Folic acid supplements (builds new blood cells)
  • *iron-chelating agents, ascorbic acid.
  • Splenectomy (if hypersplenism causing greater blood destruction $\rightarrow$ accumulation of iron elsewhere) $\rightarrow$ daily antibiotic prophylaxis

Other organs affected, e.g.
  • Pancreas $\rightarrow$ diabetes testing
  • Hypothyroidism $\rightarrow$ thyroid hormone
  • Osteoporosis $\rightarrow$ bisphosphonates, calcium
  • Liver $\rightarrow$ MRI monitoring
  • Hormone replacement
  • Gallbladder $\rightarrow$ gallbladder removal if gallstones</text>
    <formatted_text>#### General Management

- Regular blood transfusion (to treat anaemia)
- Folic acid supplements (builds new blood cells)
- Iron-chelating agents, ascorbic acid
- Splenectomy (if hypersplenism causing greater blood destruction → accumulation of iron elsewhere) → daily antibiotic prophylaxis

#### Management of Other Affected Organs

- Pancreas → diabetes testing
- Hypothyroidism → thyroid hormone
- Osteoporosis → bisphosphonates, calcium
- Liver → MRI monitoring
- Hormone replacement
- Gallbladder → gallbladder removal if gallstones</formatted_text>
  </page>
  <page number="38">
    <text>Oral Findings – Thalassaemia

• Enlargement of maxilla (“chipmunk face”) due to extramedullary haemopoiesis → OJ and OB
• Migration and spacing of upper anterior teeth
• Painful swelling of parotids and hyposalivation (due to iron deposits)
• Delayed pneumatisation of maxillary sinuses
• Teeth discoloured with short crowns/roots
• Alveolar bone with “chicken wire” radiographical appearance (extramedullary haematopoiesis)
• Sore/burning tongue (folate deficiency)
• Pale gingiva and mucosa (anaemia)

![](L5.1 haematology 1 RBC_figures/img_d3098a5109c5ca7c.webp)
![](L5.1 haematology 1 RBC_figures/img_d1759c09a9f94f75.webp)
![](L5.1 haematology 1 RBC_figures/img_42cd6ee246f855a9.webp)
![](L5.1 haematology 1 RBC_figures/img_4d558d7aa6dbe175.webp)
![](L5.1 haematology 1 RBC_figures/img_37c87654d1b03579.webp)
![](L5.1 haematology 1 RBC_figures/img_20adb3cd3903ae4e.webp)
![](L5.1 haematology 1 RBC_figures/img_5b093e46754aa796.webp)
![](L5.1 haematology 1 RBC_figures/img_52262368505afb28.webp)
![](L5.1 haematology 1 RBC_figures/img_ea5dfaab3852e2d7.webp)</text>
    <formatted_text>- Enlargement of maxilla (&quot;chipmunk face&quot;) due to extramedullary haemopoiesis → OJ and OB
- Migration and spacing of upper anterior teeth
- Painful swelling of parotids and hyposalivation (due to iron deposits)
- Delayed pneumatisation of maxillary sinuses
- Teeth discoloured with short crowns/roots
- Alveolar bone with &quot;chicken wire&quot; radiographical appearance (extramedullary haematopoiesis)
- Sore/burning tongue (folate deficiency)
- Pale gingiva and mucosa (anaemia)</formatted_text>
    <images>
      <img order="0" bbox="553,291,714,560" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_d3098a5109c5ca7c.webp">
        <description>Clinical photo: A frontal view of a young patient seated in a dental chair, showing significant maxillary enlargement (bimaxillary protrusion) and spacing of the upper anterior teeth. The facial appearance demonstrates the &quot;chipmunk face&quot; deformity associated with thalassaemia.</description>
      </img>
      <img order="1" bbox="758,297,895,565" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_d1759c09a9f94f75.webp">
        <description>Clinical photograph showing a frontal view of a patient's face exhibiting significant maxillary enlargement and forward protrusion. This results in the characteristic &quot;chipmunk face&quot; appearance, with short upper teeth visible at rest due to the skeletal changes.</description>
      </img>
      <img order="2" bbox="526,596,612,741" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_42cd6ee246f855a9.webp">
        <description>Clinical photo: A lateral profile view of a young patient's face, illustrating the midface prominence and maxillary enlargement characteristic of thalassaemia.</description>
      </img>
      <img order="3" bbox="629,596,717,740" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_4d558d7aa6dbe175.webp">
        <description>Clinical photo: A frontal facial photograph of a young patient exhibiting maxillary enlargement and spacing of the upper anterior teeth, consistent with the 'chipmunk face' appearance described in the slide text.</description>
      </img>
      <img order="4" bbox="731,596,818,740" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_37c87654d1b03579.webp">
        <description>A clinical photograph showing a young patient's face, illustrating the 'chipmunk face' appearance caused by maxillary enlargement.</description>
      </img>
      <img order="5" bbox="834,596,920,742" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_20adb3cd3903ae4e.webp">
        <description>Clinical photo: A frontal view of a young patient's face showing maxillary enlargement and spacing of the upper anterior teeth, illustrating the &quot;chipmunk face&quot; appearance associated with thalassaemia.</description>
      </img>
      <img order="6" bbox="526,748,649,831" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_5b093e46754aa796.webp">
        <description>Clinical photograph showing a lateral view of the teeth in occlusion, illustrating spacing between the upper anterior teeth and a yellowish discoloration of the enamel.</description>
      </img>
      <img order="7" bbox="662,747,785,831" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_52262368505afb28.webp">
        <description>Clinical photograph showing the anterior teeth in occlusion, illustrating spacing and migration of the upper incisors. The image also demonstrates pale gingival tissues consistent with anaemia.</description>
      </img>
      <img order="8" bbox="800,747,921,831" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L5.1 haematology 1 RBC_figures/img_ea5dfaab3852e2d7.webp">
        <description>Clinical photograph showing a lateral view of the teeth and jaws, illustrating dental spacing and migration in the upper anterior region. The image also displays an open bite condition where the front teeth do not overlap vertically.</description>
      </img>
    </images>
  </page>
  <page number="39">
    <text>Aplastic Anaemia

*   **Aplastic anaemia:** Macrocytic pancytopenia with a non-functioning bone marrow. A rare disease, characterised by suppression of multipotent myeloid stem cells causing leukopenia, thrombocytopenia and refractory anaemia.
*   **Fanconi anaemia:** inherited type of aplastic anaemia associated with progressive deficiency of all bone marrow production blood cells and increased risk of AML
*   **Causes:**
    *   Idiopathic: poor prognosis
    *   Secondary: after whole body irradiation/chemo, chemicals, drugs, hepatitis viruses, GVHD

**Box 8.14 Causes of aplastic anaemia**

*   Genetic
    *   Fanconi anaemia
    *   Dyskeratosis congenita
*   Immunological
    *   Autoimmune
    *   Graft-versus-host disease
*   Drugs
    *   Allopurinol
    *   Anticonvulsants
    *   Antithyroids
    *   Chloramphenicol
    *   Cytotoxic agents
    *   Gold
    *   Non-steroidal anti-inflammatory drugs (NSAIDs)
    *   Penicillamine
    *   Phenylbutazone
    *   Sulphonamides
*   Chemicals
    *   Benzene
    *   Glue-sniffing
    *   Heavy metals
    *   Toluene
*   Viruses
    *   Hepatitis
*   Irradiation</text>
    <formatted_text>- **Aplastic anaemia:** Macrocytic pancytopenia with a non-functioning bone marrow. A rare disease, characterised by suppression of multipotent myeloid stem cells causing leukopenia, thrombocytopenia and refractory anaemia.
- **Fanconi anaemia:** inherited type of aplastic anaemia associated with progressive deficiency of all bone marrow production blood cells and increased risk of AML

- Idiopathic: poor prognosis
- Secondary: after whole body irradiation/chemo, chemicals, drugs, hepatitis viruses, GVHD

#### Box 8.14 Causes of aplastic anaemia

- Genetic
  - Fanconi anaemia
  - Dyskeratosis congenita
- Immunological
  - Autoimmune
  - Graft-versus-host disease
- Drugs
  - Allopurinol
  - Anticonvulsants
  - Antithyroids
  - Chloramphenicol
  - Cytotoxic agents
  - Gold
  - Non-steroidal anti-inflammatory drugs (NSAIDs)
  - Penicillamine
  - Phenylbutazone
  - Sulphonamides
- Chemicals
  - Benzene
  - Glue-sniffing
  - Heavy metals
  - Toluene
- Viruses
  - Hepatitis
- Irradiation</formatted_text>
  </page>
  <page number="40">
    <text>Aplastic Anaemia

*   **Features:** those of anaemia + abnormal susceptibility to infection/bleeding
    *   Purpura, petechiae, ecchymoses
    *   Predisposition to infection
    *   Weakness, pallor, dyspnoea</text>
    <formatted_text>**Features:** those of anaemia + abnormal susceptibility to infection/bleeding

- Purpura, petechiae, ecchymoses
- Predisposition to infection
- Weakness, pallor, dyspnoea</formatted_text>
  </page>
  <page number="41">
    <text># Aplastic Anaemia

*   **General Management:**
    *   Remove cause
    *   Isolation and antibiotics to control infection
    *   immunosuppression
    *   Blood transfusion
    *   Stem cell transplant

*   **Prognosis** - if treated
    *   90% for 19-39yo
    *   70% for 40-59yo
    *   38% for &gt;60yo
    *   Can evolve into AML</text>
    <formatted_text>**General Management:**

- Remove cause
- Isolation and antibiotics to control infection
- Immunosuppression
- Blood transfusion
- Stem cell transplant

**Prognosis** — if treated:

- 90% for 19–39yo
- 70% for 40–59yo
- 38% for &gt;60yo
- Can evolve into AML</formatted_text>
    <audio_inserts count="4">
      <insert timestamp="00:15:48" confidence="7" anchor="- Remove cause - Isolation and antibiotics to control infection - Immunosuppress">
- ==Patients with aplastic anaemia may be encountered in hospital settings during assessment for stem cell transplantation.==</insert>
      <insert timestamp="00:36:02" confidence="7" anchor="#### **Questions for Patient** - Are you transfusion-dependent? - How many times">
- ==Transfusion dependence gives an indication of disease control and severity.==
- ==Shortness of breath has implications for airway management and positioning.==
- ==Ask about triggers for shortness of breath.==
- ==Establish whether the patient has had a splenectomy.==
- ==Ask about other affected organs and relevant complications.==
- ==Establish whether the patient is receiving exchange transfusions.==
- ==Determine whether the patient may be heparinised or otherwise anticoagulated.==</insert>
      <insert timestamp="00:36:49" confidence="3" anchor="#### **Risks Specific to Thalassaemia (Especially Beta-Thalassaemia Major)** - S">
- ==Cardiomyopathy from iron deposition may progress to cardiac failure.==
- ==The risks depend on which organs have been affected.==</insert>
      <insert timestamp="00:38:30" confidence="4" anchor="#### **Risks Specific to Sickle Cell Anaemia** - Timing around transfusions - Ox">
- ==Dental treatment should not be carried out on the same day as an exchange transfusion.==
- ==Treatment may be possible the following day once the heparin has cleared.==
- ==Anticoagulation may increase bleeding risks during dental treatment.==</insert>
    </audio_inserts>
  </page>
  <page number="42">
    <text>Aplastic Anaemia

*   **Dental management**
    *   Oral features:
        *   similar to leukaemia (ulceration, infection susceptibility, haemorrhaging tendencies)
        *   Oral lichenoid lesions
        *   Sjogren-like syndrome of GVHD
        *   Gingiva enlargement (ciclosporin, or AML transformation)</text>
    <formatted_text>**Dental management**

Oral features:

- Similar to leukaemia (ulceration, infection susceptibility, haemorrhaging tendencies)
- Oral lichenoid lesions
- Sjogren-like syndrome of GVHD
- Gingiva enlargement (ciclosporin, or AML transformation)</formatted_text>
  </page>
  <page number="43">
    <text/>
  </page>
  <page number="44">
    <text># Risk Assessment

**Red blood cell count (&gt;80-100 g/L)**

**Questions for patient**
*   Are you transfusion-dependent?
*   How many times per week/month?
*   Do you experience SOB? (if so, when)

**Risks specific to thalassaemia (especially beta-thalassaemia major)**
*   Splenectomy = infection risks
*   Osteoporosis (possible MRONJ risk)
*   Cardiomyopathy and cardiac failure
*   Liver cirrhosis
*   Kidney
*   Diabetes (secondary to pancreas iron deposition)
*   Thyroid/parathyroid damage

**Risks specific to sickle cell anaemia**
*   Timing around transfusions
*   Oxygen support
*   Infection risks
*   Carrying out treatment during phase when haemolysis is minimal
*   *Depends on other organs affected
*   Heparinised for exchange transfusions</text>
    <formatted_text>**Red blood cell count (&gt;80–100 g/L)**

#### Questions for Patient
- Are you transfusion-dependent?
- How many times per week/month?
- Do you experience shortness of breath? (if so, when)

#### Risks Specific to Thalassaemia (Especially Beta-Thalassaemia Major)
- Splenectomy = infection risks
- Osteoporosis (possible MRONJ risk)
- Cardiomyopathy and cardiac failure
- Liver cirrhosis
- Kidney
- Diabetes (secondary to pancreas iron deposition)
- Thyroid/parathyroid damage

#### Risks Specific to Sickle Cell Anaemia
- Timing around transfusions
- Oxygen support
- Infection risks
- Carrying out treatment during phase when haemolysis is minimal
- Depends on other organs affected
- Heparinised for exchange transfusions</formatted_text>
  </page>
  <page number="45">
    <text># Dental Management

**Access:**
• Short appointments in morning to ensure patient not too fatigued.
• If patient receives regular exchange/blood transfusions, avoid treatment on same day (will also be heparinised)

**Communication/Consent:**
• Nil significant

**Education/Prevention:**
• Ensure strict OH regime and prevention education to avoid need for dental treatment
• Removeable prosthetics may be unable to be tolerated when oral ulcers present</text>
    <formatted_text>#### Access
- Short appointments in morning to ensure patient not too fatigued.
- If patient receives regular exchange/blood transfusions, avoid treatment on same day (will also be heparinised).

#### Communication/Consent
- Nil significant

#### Education/Prevention
- Ensure strict oral hygiene regime and prevention education to avoid need for dental treatment.
- Removable prosthetics may be unable to be tolerated when oral ulcers present.</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:38:38" confidence="4" anchor="- If patient receives regular exchange/blood transfusions, avoid treatment on sa">

&gt; [!note] Lecturer — Transfusion Timing
&gt; Treatment should be coordinated around transfusions. Treatment may be carried out the following day after heparin has cleared.
</insert>
      <insert timestamp="00:39:08" confidence="6" anchor="- Ensure strict oral hygiene regime and prevention education to avoid need for d">

&gt; [!note] Lecturer — Communication and Prevention
&gt; Visual disturbances caused by vascular complications may create communication difficulties. The patient’s systemic disease, transfusion dependence and organ involvement should be established before treatment, and consent should account for the increased risks associated with anaemia, haemolysis, infection, bleeding and affected organs.
&gt;
&gt; - Anaemia can be associated with oral ulceration, and the mouth may be more sore during dental procedures.
</insert>
    </audio_inserts>
  </page>
  <page number="46">
    <text>Dental Management

**Surgery – Pre-operative**
*   Haemoglobin assay/complete blood count performed
*   Ideally correct anaemia prior to dental treatment and check Hb level raised
    *   if necessary, by transfusion in emergency
*   Patient stabilised at least 24hrs pre-operatively.
    *   Hb estimations are unreliable for 12hrs post-transfusion or after acute blood loss

*   Caution advised if &lt;80g/L: ideally only emergency dental treatment to stabilise dentition with peri-operative nasal oxygen/pulse oximeter.</text>
    <formatted_text>#### Surgery – Pre-Operative
- Haemoglobin assay/complete blood count performed.
- Ideally correct anaemia prior to dental treatment and check Hb level raised, if necessary by transfusion in emergency.
- Patient stabilised at least 24 hrs pre-operatively.
  - Hb estimations are unreliable for 12 hrs post-transfusion or after acute blood loss.

&gt; Caution advised if &lt;80 g/L: ideally only emergency dental treatment to stabilise dentition with peri-operative nasal oxygen/pulse oximeter.</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:40:11" confidence="10" anchor="- Hb estimations are unreliable for 12 hrs post-transfusion or after acute blood">

&gt; [!note] Lecturer — Blood Count Interpretation
&gt; Blood counts should be interpreted cautiously because they do not necessarily show the functional status of red blood cells or the function of other blood cell lines. Blood counts do not rise immediately after transfusion, and the same principle applies after acute blood loss because compensatory mechanisms take time to develop.
</insert>
    </audio_inserts>
  </page>
  <page number="47">
    <text>Dental Management

**Surgery – Peri-operative**
• Consider supplemental nasal oxygen (3L/min) if Hb &lt;80-100g/L
• [SCA] Avoid prilocaine (risk: methemoglobinemia)
• Nitrous oxide contraindicated in Vit B12 deficiency
  • interferes with B12 metabolism
• Deeper levels of sedation – risk of hypoxia
  • Reconsider elective IV/GA’s if Hb &lt;80-100g/L
• [SCA/Th] Consider prophylactic/surgical antibiotics in post-splenectomy patients</text>
    <formatted_text>#### Surgery – Peri-Operative
- Consider supplemental nasal oxygen (3 L/min) if Hb &lt;80–100 g/L.
- [SCA] Avoid prilocaine (risk: methemoglobinemia).
- Nitrous oxide contraindicated in Vit B12 deficiency — interferes with B12 metabolism.
- Deeper levels of sedation — risk of hypoxia; reconsider elective IV/GA's if Hb &lt;80–100 g/L.
- [SCA/Th] Consider prophylactic/surgical antibiotics in post-splenectomy patients.</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:41:55" confidence="6" anchor="- Deeper levels of sedation — risk of hypoxia; reconsider elective IV/GA's if Hb">

&gt; [!note] Lecturer — Anaesthesia Risks
&gt; The myocardium may be unable to respond adequately to the demands of anaesthesia or sedation. Severe anaemia therefore increases the risk of hypoxia during deeper sedation, including intravenous sedation and general anaesthesia.
</insert>
    </audio_inserts>
  </page>
  <page number="48">
    <text>Dental Management

**Spread**
• Standard infection control: risk of BBVs in older patients receiving recurrent transfusions prior to current blood product screening standards
• Consider antibiotic prophylaxis if:
  • Other cell lines affected
  • Splenectomy
  • Sickle cell disease</text>
    <formatted_text>#### Infection Control Considerations
- Standard infection control: risk of BBVs in older patients receiving recurrent transfusions prior to current blood product screening standards.

#### Antibiotic Prophylaxis
Consider antibiotic prophylaxis if:
- Other cell lines affected
- Splenectomy
- Sickle cell disease</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:42:22" confidence="10" anchor="- Standard infection control: risk of BBVs in older patients receiving recurrent">

&gt; [!note] Lecturer — Blood-Borne Viruses
&gt; Some older patients who received regular transfusions throughout their lives may have acquired blood-borne viruses when blood-product screening was less rigorous. Possible blood-borne viruses include HIV, hepatitis B and hepatitis C.
</insert>
      <insert timestamp="00:42:50" confidence="13" anchor="- Sickle cell disease">

&gt; [!note] Lecturer — Antibiotic Prophylaxis
&gt; Patients with thalassaemia who have had a splenectomy require antibiotic prophylaxis. Long-term penicillin may be used in sickle cell disease to reduce infection risk, and patients with sickle cell disease may have more profound immunocompromise.
</insert>
    </audio_inserts>
  </page>
  <page number="49">
    <text>Questions?

■ **Jeeyun.Leung@uwa.edu.au**</text>
    <formatted_text>Questions?

**Jeeyun.Leung@uwa.edu.au**</formatted_text>
  </page>
  <page number="50" origin="cases">
    <text>## Case: Fingernail exhibiting spooning

### Question

**Scenario:** A clinical photograph of a fingernail is presented to illustrate the physical features of a specific type of anaemia.

**What's shown:** A close-up clinical photograph of a fingernail.

**Consider:** Identify the specific nail abnormality visible on the image and the associated type of anaemia.


### Answer

**Observations:**
- The fingernail exhibits a concave, spoon-like shape (spooning/koilonychia).

**Reasoning:** The lecturer points out the spooning of the nail on the image, identifying it as a classic clinical feature of iron deficiency anaemia, alongside other symptoms such as weakness and hair loss.

**Outcome:** None stated for this exhibit.

**Takeaway:** Spooning of the nails (koilonychia) is a classic clinical feature of iron deficiency anaemia.

## Case: Panoramic radiograph showing mandibular and skull changes

### Question

**Scenario:** A panoramic radiograph is presented to illustrate the radiological features associated with sickle cell anemia.

**What's shown:** A panoramic dental radiograph (OPG).

**Consider:** Identify the radiological findings visible in the image and relate them to the underlying pathophysiology of the condition.


### Answer

**Observations:**
- Increased radiolucency in the inferior body of the mandible, indicating a sparse mandibular trabecular bone pattern.
- Thickening and expansion of the skull diploë (the middle layer of spongy bone in the flat bones of the skull).
- A &quot;hair on end&quot; appearance of the skull.
- Dense radiopacities with a stepladder trabecular pattern.

**Reasoning:** The increased radiolucency in the mandible and the expansion of the skull diploë are a result of bone marrow hyperplasia, as the body struggles to produce red blood cells normally. The &quot;hair on end&quot; appearance is a classic sign of this diploë expansion. The dense radiopacities with a stepladder trabecular pattern correlate with previous bone infarcts from sickle crises.

**Outcome:** None stated for this specific exhibit.

**Takeaway:** Sickle cell anemia causes bone marrow hyperplasia that leads to distinct radiological features, including sparse mandibular trabeculation, expansion of the skull diploë with a &quot;hair on end&quot; appearance, and stepladder trabecular patterns resulting from previous infarcts.</text>
    <formatted_text>## Case: Fingernail exhibiting spooning

### Question

**Scenario:** A clinical photograph of a fingernail is presented to illustrate the physical features of a specific type of anaemia.

**What's shown:** A close-up clinical photograph of a fingernail.

**Consider:** Identify the specific nail abnormality visible on the image and the associated type of anaemia.


![](L5.1 haematology 1 RBC_cases_attachments/img_d65bd98dc1b7717c.webp)
### Answer

**Observations:**
- The fingernail exhibits a concave, spoon-like shape (spooning/koilonychia).

**Reasoning:** The lecturer points out the spooning of the nail on the image, identifying it as a classic clinical feature of iron deficiency anaemia, alongside other symptoms such as weakness and hair loss.

**Outcome:** None stated for this exhibit.

**Takeaway:** Spooning of the nails (koilonychia) is a classic clinical feature of iron deficiency anaemia.

## Case: Panoramic radiograph showing mandibular and skull changes

### Question

**Scenario:** A panoramic radiograph is presented to illustrate the radiological features associated with sickle cell anemia.

**What's shown:** A panoramic dental radiograph (OPG).

**Consider:** Identify the radiological findings visible in the image and relate them to the underlying pathophysiology of the condition.


![](L5.1 haematology 1 RBC_cases_attachments/img_3f1f38500e38a4a9.webp)
### Answer

**Observations:**
- Increased radiolucency in the inferior body of the mandible, indicating a sparse mandibular trabecular bone pattern.
- Thickening and expansion of the skull diploë (the middle layer of spongy bone in the flat bones of the skull).
- A &quot;hair on end&quot; appearance of the skull.
- Dense radiopacities with a stepladder trabecular pattern.

**Reasoning:** The increased radiolucency in the mandible and the expansion of the skull diploë are a result of bone marrow hyperplasia, as the body struggles to produce red blood cells normally. The &quot;hair on end&quot; appearance is a classic sign of this diploë expansion. The dense radiopacities with a stepladder trabecular pattern correlate with previous bone infarcts from sickle crises.

**Outcome:** None stated for this specific exhibit.

**Takeaway:** Sickle cell anemia causes bone marrow hyperplasia that leads to distinct radiological features, including sparse mandibular trabeculation, expansion of the skull diploë with a &quot;hair on end&quot; appearance, and stepladder trabecular patterns resulting from previous infarcts.</formatted_text>
    <heading_path>Case: Fingernail exhibiting spooning</heading_path>
    <images>
      <img order="0" type="photo" path="L5.1 haematology 1 RBC_figures/img_d65bd98dc1b7717c.webp" media="frame" source="slide" page="20" timestamp="00:09:55">
        <description>Clinical photo: A close-up of a fingernail exhibiting koilonychia, characterized by a concave, spoon-shaped deformity of the nail plate.</description>
      </img>
      <img order="1" type="figure" path="L5.1 haematology 1 RBC_figures/img_3f1f38500e38a4a9.webp" media="frame" source="slide" page="33" timestamp="00:23:18">
        <description>Increased radiolucency of the bone in the inferior body of the mandible (Grossman S, Bailey E, Makdissi J. Oral aspects of sickle cell disease, Br Dent J. 2019; 226: 818) A panoramic dental radiograph (orthopantomogram) showing the maxilla and mandible with a full set of teeth. The image illustrates increased radiolucency in the inferior body of the mandible, appearing as a sparse trabecular bone pattern compared to the denser surrounding structures.</description>
      </img>
    </images>
  </page>
  <footnotes>[^1]: Original PDF page 1: [[L5.1 haematology 1 RBC.pdf#page=1|L5.1 haematology 1 RBC, p.1]]
[^2]: Original PDF page 2: [[L5.1 haematology 1 RBC.pdf#page=2|L5.1 haematology 1 RBC, p.2]]
[^3]: Original PDF page 3: [[L5.1 haematology 1 RBC.pdf#page=3|L5.1 haematology 1 RBC, p.3]]
[^4]: Original PDF page 4: [[L5.1 haematology 1 RBC.pdf#page=4|L5.1 haematology 1 RBC, p.4]]
[^5]: Original PDF page 5: [[L5.1 haematology 1 RBC.pdf#page=5|L5.1 haematology 1 RBC, p.5]]
[^6]: Original PDF page 6: [[L5.1 haematology 1 RBC.pdf#page=6|L5.1 haematology 1 RBC, p.6]]
[^7]: Original PDF page 7: [[L5.1 haematology 1 RBC.pdf#page=7|L5.1 haematology 1 RBC, p.7]]
[^8]: Original PDF page 8: [[L5.1 haematology 1 RBC.pdf#page=8|L5.1 haematology 1 RBC, p.8]]
[^9]: Original PDF page 9: [[L5.1 haematology 1 RBC.pdf#page=9|L5.1 haematology 1 RBC, p.9]]
[^10]: Original PDF page 10: [[L5.1 haematology 1 RBC.pdf#page=10|L5.1 haematology 1 RBC, p.10]]
[^11]: Original PDF page 11: [[L5.1 haematology 1 RBC.pdf#page=11|L5.1 haematology 1 RBC, p.11]]
[^12]: Original PDF page 12: [[L5.1 haematology 1 RBC.pdf#page=12|L5.1 haematology 1 RBC, p.12]]
[^13]: Original PDF page 13: [[L5.1 haematology 1 RBC.pdf#page=13|L5.1 haematology 1 RBC, p.13]]
[^14]: Original PDF page 14: [[L5.1 haematology 1 RBC.pdf#page=14|L5.1 haematology 1 RBC, p.14]]
[^15]: Original PDF page 15: [[L5.1 haematology 1 RBC.pdf#page=15|L5.1 haematology 1 RBC, p.15]]
[^16]: Original PDF page 16: [[L5.1 haematology 1 RBC.pdf#page=16|L5.1 haematology 1 RBC, p.16]]
[^17]: Original PDF page 17: [[L5.1 haematology 1 RBC.pdf#page=17|L5.1 haematology 1 RBC, p.17]]
[^18]: Original PDF page 18: [[L5.1 haematology 1 RBC.pdf#page=18|L5.1 haematology 1 RBC, p.18]]
[^19]: Original PDF page 19: [[L5.1 haematology 1 RBC.pdf#page=19|L5.1 haematology 1 RBC, p.19]]
[^20]: Original PDF page 20: [[L5.1 haematology 1 RBC.pdf#page=20|L5.1 haematology 1 RBC, p.20]]
[^21]: Original PDF page 21: [[L5.1 haematology 1 RBC.pdf#page=21|L5.1 haematology 1 RBC, p.21]]
[^22]: Original PDF page 22: [[L5.1 haematology 1 RBC.pdf#page=22|L5.1 haematology 1 RBC, p.22]]
[^23]: Original PDF page 23: [[L5.1 haematology 1 RBC.pdf#page=23|L5.1 haematology 1 RBC, p.23]]
[^24]: Original PDF page 24: [[L5.1 haematology 1 RBC.pdf#page=24|L5.1 haematology 1 RBC, p.24]]
[^25]: Original PDF page 25: [[L5.1 haematology 1 RBC.pdf#page=25|L5.1 haematology 1 RBC, p.25]]
[^26]: Original PDF page 26: [[L5.1 haematology 1 RBC.pdf#page=26|L5.1 haematology 1 RBC, p.26]]
[^27]: Original PDF page 27: [[L5.1 haematology 1 RBC.pdf#page=27|L5.1 haematology 1 RBC, p.27]]
[^28]: Original PDF page 28: [[L5.1 haematology 1 RBC.pdf#page=28|L5.1 haematology 1 RBC, p.28]]
[^29]: Original PDF page 29: [[L5.1 haematology 1 RBC.pdf#page=29|L5.1 haematology 1 RBC, p.29]]
[^30]: Original PDF page 30: [[L5.1 haematology 1 RBC.pdf#page=30|L5.1 haematology 1 RBC, p.30]]
[^31]: Original PDF page 31: [[L5.1 haematology 1 RBC.pdf#page=31|L5.1 haematology 1 RBC, p.31]]
[^32]: Original PDF page 32: [[L5.1 haematology 1 RBC.pdf#page=32|L5.1 haematology 1 RBC, p.32]]
[^33]: Original PDF page 33: [[L5.1 haematology 1 RBC.pdf#page=33|L5.1 haematology 1 RBC, p.33]]
[^34]: Original PDF page 34: [[L5.1 haematology 1 RBC.pdf#page=34|L5.1 haematology 1 RBC, p.34]]
[^35]: Original PDF page 35: [[L5.1 haematology 1 RBC.pdf#page=35|L5.1 haematology 1 RBC, p.35]]
[^36]: Original PDF page 36: [[L5.1 haematology 1 RBC.pdf#page=36|L5.1 haematology 1 RBC, p.36]]
[^37]: Original PDF page 37: [[L5.1 haematology 1 RBC.pdf#page=37|L5.1 haematology 1 RBC, p.37]]
[^38]: Original PDF page 38: [[L5.1 haematology 1 RBC.pdf#page=38|L5.1 haematology 1 RBC, p.38]]
[^39]: Original PDF page 39: [[L5.1 haematology 1 RBC.pdf#page=39|L5.1 haematology 1 RBC, p.39]]
[^40]: Original PDF page 40: [[L5.1 haematology 1 RBC.pdf#page=40|L5.1 haematology 1 RBC, p.40]]
[^41]: Original PDF page 41: [[L5.1 haematology 1 RBC.pdf#page=41|L5.1 haematology 1 RBC, p.41]]
[^42]: Original PDF page 42: [[L5.1 haematology 1 RBC.pdf#page=42|L5.1 haematology 1 RBC, p.42]]
[^43]: Original PDF page 43: [[L5.1 haematology 1 RBC.pdf#page=43|L5.1 haematology 1 RBC, p.43]]
[^44]: Original PDF page 44: [[L5.1 haematology 1 RBC.pdf#page=44|L5.1 haematology 1 RBC, p.44]]
[^45]: Original PDF page 45: [[L5.1 haematology 1 RBC.pdf#page=45|L5.1 haematology 1 RBC, p.45]]
[^46]: Original PDF page 46: [[L5.1 haematology 1 RBC.pdf#page=46|L5.1 haematology 1 RBC, p.46]]
[^47]: Original PDF page 47: [[L5.1 haematology 1 RBC.pdf#page=47|L5.1 haematology 1 RBC, p.47]]
[^48]: Original PDF page 48: [[L5.1 haematology 1 RBC.pdf#page=48|L5.1 haematology 1 RBC, p.48]]
[^49]: Original PDF page 49: [[L5.1 haematology 1 RBC.pdf#page=49|L5.1 haematology 1 RBC, p.49]]</footnotes>
</document>
